© 2022 MJH Life Sciences and Modern Retina. All rights reserved.
© 2022 MJH Life Sciences™ and Modern Retina. All rights reserved.
July 15, 2021
Promoting Tie2 signaling activity may complement inhibition of VEGF in addressing pathology in disease states characterized by angiogenesis, vascular permeability, and inflammation.
June 24, 2021
In a study, a single intravitreal injection of ADVM-022 had a 99% reduction in the mean annualized frequency of anti-VEGF injections.
June 23, 2021
Investigators corroborate the hypothesis that retinal ganglion cells with dendrites stratified in the off sublaminae could be damaged.
June 21, 2021
In endophthalmitis, the systemic anti-infective treatment specific to the infectious agent should always be used.
June 18, 2021
According to investigators, the new technology is designed to detect telltale signs of major blinding diseases in retinal blood and tissue that typically go unseen until it is too late.
June 17, 2021
Amid pandemic, physicians and patients have embraced remote technology.
June 07, 2021
The not-for-profit vision and healthcare organization breaks ground on premier Technology Center for assistive technology for people with vision loss.
June 01, 2021
Retinal imaging tests are providing material to train and test decision support systems.
May 25, 2021
Preexisting neutralizing antibodies associated with the inflammatory changes.
May 21, 2021
Novel therapies are shifting the paradigm in care of retinal diseases